Alphanate (Antihemophilic factor/von Willebrand factor complex [human]) for Hemophilia

Overview
Alphanate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Alphanate is also used in people with von Willebrand disease during surgery or other invasive procedures when Stimate is not effective. The technical name of Alphanate is Antihemophilic factor/von Willebrand factor complex (human).

Alphanate is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.

How do I take it?
Prescribing information states that Alphanate is given as an intravenous injection.

Alphanate comes as a powder that must be reconstituted before injection.

Side effects
The FDA-approved label for Alphanate lists common side effects including itching, rash, chills, facial swelling, back pain, headache, respiratory distress, and numbness or tingling.

Rare but serious side effects listed for Alphanate include the transmission of infections, thromboembolic events, the development of inhibitors, and life-threatening hypersensitivity reactions.

For more details about this treatment, visit:

Alphanate.com

Treatment of Hemophilia – Hemophilia Federation of America